M-9, r. 12.2.1 - Regulation respecting certain professional activities that may be engaged in by a pharmacist

Section 2 Disposition versions

2021-01-25

2. In the practice of his or her profession, a pharmacist may prescribe medication referred to in Schedule I to the Regulation respecting the terms and conditions for the sale of medications (chapter P-10, r. 12) to a patient who has received treatment for one of the following health problems in the past:

(1)  minor acne (without nodules or pustules);

(2)  mouth ulcers;

(3)  dermal candidiasis;

(4)  oral candidiasis;

(5)  allergic conjunctivitis;

(6)  atopic dermatitis requiring the use of a moderate strength of corticosteroids;

(7)  primary dysmenorrhea;

(8)  diaper rash;

(9)  hemorrhoids;

(10)  herpes labialis;

(11)  urinary infections in women, where the patient has received not more than one treatment for that health problem in the last 6 months or not more than 2 treatments in the last 12 months;

(12)  allergic rhinitis;

(13)  yeast vaginitis.

However, a pharmacist may not prescribe medication where more than 5 years have elapsed since the last treatment prescribed for that same health problem by another professional empowered to prescribe medication. For the treatment of oral candidiasis not resulting from the use of a corticosteroid inhaler and the health problems referred to in subparagraphs 7 and 9 of the first paragraph, that time period is reduced by 2 years.

In addition, medication prescribed under this section must belong to a class of medications of equal or lesser strength than the medication prescribed in the past.

O.C. 1400-2020, s. 2.

Not in force

In force: 2021-01-25

2. In the practice of his or her profession, a pharmacist may prescribe medication referred to in Schedule I to the Regulation respecting the terms and conditions for the sale of medications (chapter P-10, r. 12) to a patient who has received treatment for one of the following health problems in the past:

(1)  minor acne (without nodules or pustules);

(2)  mouth ulcers;

(3)  dermal candidiasis;

(4)  oral candidiasis;

(5)  allergic conjunctivitis;

(6)  atopic dermatitis requiring the use of a moderate strength of corticosteroids;

(7)  primary dysmenorrhea;

(8)  diaper rash;

(9)  hemorrhoids;

(10)  herpes labialis;

(11)  urinary infections in women, where the patient has received not more than one treatment for that health problem in the last 6 months or not more than 2 treatments in the last 12 months;

(12)  allergic rhinitis;

(13)  yeast vaginitis.

However, a pharmacist may not prescribe medication where more than 5 years have elapsed since the last treatment prescribed for that same health problem by another professional empowered to prescribe medication. For the treatment of oral candidiasis not resulting from the use of a corticosteroid inhaler and the health problems referred to in subparagraphs 7 and 9 of the first paragraph, that time period is reduced by 2 years.

In addition, medication prescribed under this section must belong to a class of medications of equal or lesser strength than the medication prescribed in the past.

O.C. 1400-2020, s. 2.